Skip to contentT
TuHURA Biosciences, Inc.
T
HURATuHURA Biosciences, Inc. Q2 2025 · 10-Q
Revenue$0.00$0.00derived— vs Q2 2024 Net Income-$9.52M-$9.52MN/M vs Q2 2024 EPS Diluted-$0.21-$0.21N/M vs Q2 2024 Operating Cash Flowderived-$6,248,162N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
TuHURA Biosciences, Inc. · CIK 1498382 · Engraved from SEC EDGAR
Free Cash Flowderived-$6,253,723— ended Jun 30, 2025 · filed Aug 14, 2025 · 45 d after period end